Interestingly, our data showed that pharmacological inhibition of USP7 in vivo in Apcmin mice was well tolerated and resulted in a significant decrease in tumor numbers with no signs of colitis or enteritis after 21 days treatment. This evidence concerns the gene USP7 and colitis.